Simplifying Treatment and Reducing Recurrence for Patients With Early-Stage Bladder Cancer

被引：5
|
作者：
Kaffenberger, Samuel D. [1 ]
Miller, David C. [1 ]
Nielsen, Matthew E. [2 ,3 ,4 ,5 ]
机构：
[1] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
[2] Univ N Carolina, Dept Urol, 2107 Phys Off Bldg,Campus Box 7235, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA
[4] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA
[5] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 319卷 / 18期
基金：
美国国家卫生研究院;
关键词：
MITOMYCIN-C; INSTILLATION; CARCINOMA; IMPROVE;
D O I：
10.1001/jama.2018.4656
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1864 / 1865
页数：2
相关论文
共 50 条
  • [1] Provider Treatment Intensity and Outcomes for Patients With Early-Stage Bladder Cancer
    Hollenbeck, Brent K.
    Ye, Zaojun
    Dunn, Rodney L.
    Montie, James E.
    Birkmeyer, John D.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (08): : 571 - 580
  • [2] Extent of Risk-Aligned Surveillance for Cancer Recurrence Among Patients With Early-Stage Bladder Cancer
    Schroeck, Florian R.
    Lynch, Kristine E.
    Chang, Ji Won
    MacKenzie, Todd A.
    Seigne, John D.
    Robertson, Douglas J.
    Goodney, Philip P.
    Sirovich, Brenda
    JAMA NETWORK OPEN, 2018, 1 (05)
  • [3] SURVIVAL AFTER RECURRENCE IN EARLY-STAGE CERVICAL CANCER PATIENTS
    Van Lonkhuijzen, L.
    Dostalek, L.
    Jarkovsky, J.
    Lopez, A.
    Falconer, H.
    Scambia, G.
    Ayhan, A.
    Kim, S.
    Isla Ortiz, D.
    Klat, J.
    Obermair, A.
    Martino, Gdi
    Pareja, R.
    Manchanda, R.
    Kostun, J.
    Dos Reis, R.
    Zapardiel, I.
    Weinberger, V.
    Cibula, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A53 - A55
  • [4] Provider Treatment Intensity and Outcomes for Patients With Early-Stage Bladder Cancer Editorial Comment
    Montie, James E.
    JOURNAL OF UROLOGY, 2010, 183 (01): : 101 - 101
  • [5] Hormonal treatment (HT) and late recurrence in early-stage breast cancer (BC) patients.
    Barcenas, Carlos Hernando
    Sinha, Arup Kumar
    Hortobagyi, Gabriel N.
    Valero, Vicente
    Ueno, Naoto T.
    Giordano, Sharon Hermes
    Chavez-Mac Gregor, Mariana
    Brewster, Abenaa M.
    Lucci, Anthony
    Tripathy, Debu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer
    Ditto, Antonino
    Maggiore, Umberto Leone Roberti
    Bogani, Giorgio
    Martinelli, Fabio
    Chiappa, Valentina
    Evangelista, Maria Teresa
    Liberale, Viola
    Ferrero, Simone
    Raspagliesi, Francesco
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 145 (01) : 28 - 33
  • [7] Genomic alterations associated with early-stage disease and early recurrence in patients with colorectal cancer
    Pappas, Leontios
    Quintanilha, Julia C. F.
    Huang, Richard S. P.
    Parikh, Aparna R.
    ONCOLOGIST, 2024,
  • [8] Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer
    Dalberg, K
    Mattsson, A
    Sandelin, K
    Rutqvist, LE
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (01) : 69 - 78
  • [9] Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer
    Kristina Dalberg
    Anders Mattsson
    Kerstin Sandelin
    Lars E. Rutqvist
    Breast Cancer Research and Treatment, 1998, 49 : 69 - 78
  • [10] METABOLIC COMPONENTS AND RECURRENCE IN EARLY-STAGE CERVICAL CANCER
    Hwang, I. C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S177 - S177
12345